Trump's HHS halts multi-million dollar Biden era contract to create a new COVID-19 vaccine.
So you had RFK Jr. has halted a Biden era contract to create this new vaccine.
He says, quote, Now, keep that in mind.
That isn't just a shot at the Biden administration.
This is absolute truth.
There was literally no oversight for monies or research when it came to COVID jabs, COVID vaccines as well.
As well as virtually everything else is what we're finding out now through all of the things that are being exposed through Doge.
RFK Jr. goes on.
Quote.
I look forward to working with VaxArt and medical experts to ensure this work produces safe, effective, and fiscal-minded vaccine technology.
Now, that's some of the things that we've been wanting all along.
Is it fiscally responsible?
Is it safe?
Is it effective?
Is it really a vaccine?
Or is it a therapeutic, which many of these so-called vaccines turned out to be?
The HHS contract, according to Breitbart, is with American biotech company VaxArt.
Which has been developing a new COVID-19 vaccine that is taken orally.
So Kennedy didn't terminate the contract, for all of you out there.
Instead, the trial is paused.
It's a 90-day pause to stop the work order, and that was issued on Friday.
The stop work order came ahead at the beginning of clinical trials on Monday with 10,000 individuals.
So no oversight by the federal government.
10,000 individuals that were going to be lab rats for this vaccine and it had not been reviewed by the Department of Health and Human Services.
You got that?
The contract is part of the Biden administration's $4.7 billion Project Next Generation Initiative, which it launched in 2023. They did so in order to streamline the development of new vaccines, according to the report.
The VaxArt vaccine is funded through an agreement with BARDA. BARDA, B-A-R-A-D-A, is an acronym, and that stands for Biomedical Advanced Research and Development Authority.
That comes under the Department and the Administration for Strategic Preparedness and Response within the HHS. BARDA had obligated $460 million for the development of VaxArt's COVID-19 vaccine.
$240 million had already been dispersed for the preliminary study.
However, the stop work order prevents VaxArt from invoicing BARDA. Basically, within the HHS, the remaining $230 million for clinical trials until further notice.
According to the report, VaxArt is still able to invoice HHS for medical monitoring of the people who took part in early trials.
The pause comes less than two weeks after Kennedy's confirmation.
All right, so this is a good thing.
I mean, we're going to be spending all this money for vaccines, and there's no telling.
Let's be honest.
There's no telling how these people, VaxArt, and listen, I simply don't know.
I'm not accusing VaxArt of anything, but do we know how these people were able to secure that money from the federal government?
$490 million, more than half of it being paid out already?